Chronic graft-versus-host disease
$857,663ZIAFY2021CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 33526918Paper 33347890Paper 32976576Paper 32791068Paper 30994870Paper 28437849Paper 27694491Paper 27179943Paper 26964058Paper 26088932Paper 25771402Paper 25740857Paper 25529383Paper 25363867Paper 25207994Paper 25153693Paper 25029231Paper 24993601Paper 24819543
Abstract
This effort continues to be very productive as evidenced by the yearly publication output related to GVHD, including publication of the Branch initiated imatinib clinical trial. In addition, I have made several important contributions to the identification of novel skin manifestations of cGVHD, as well as identified the role of total body irradiation as a risk factor for cGVHD. Current projects including ssRNA analysis of cutaneous GVHD specimens to better understand the pathophysiology of skin disease. Clinical projects including the first topical study of ruxolitinib for skin GVHD and a case series on cutaneous calcinosis in skin GVHD.
View original record on NIH RePORTER →